CARing about autoimmune disorders. Use of chimeric antigen receptor engineered T-cells in autoimmune diseases.
Saved in:
| Title: | CARing about autoimmune disorders. Use of chimeric antigen receptor engineered T-cells in autoimmune diseases. |
|---|---|
| Authors: | Tigu AB; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania., Nistor M; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania., Gulei D; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania., Constantinescu CS; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; Department of Anesthesia and Intensive Care, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; Intensive Care Unit, Emergency Clinical Hospital, Cluj-Napoca, Romania., Kegyes D; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; Department of Hematology, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania., Cenariu D; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania., Muresan X; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania., Munteanu R; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania., Feder R; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania., Jitaru C; Department of Hematology, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; Department of Hematology, Ion Chiricuta Oncology Institute, Cluj-Napoca, Romania., Bancos A; Department of Hematology, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; Department of Hematology, Ion Chiricuta Oncology Institute, Cluj-Napoca, Romania., Santa M; Department of Hematology, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; Department of Hematology, Ion Chiricuta Oncology Institute, Cluj-Napoca, Romania., Tomai R; Department of Hematology, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; Department of Hematology, Ion Chiricuta Oncology Institute, Cluj-Napoca, Romania., Damian M; Department of Hematology, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; Department of Hematology, Ion Chiricuta Oncology Institute, Cluj-Napoca, Romania., Ivancuta A; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania., Rus I; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania., Bojan A; Department of Hematology, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; Department of Hematology, Ion Chiricuta Oncology Institute, Cluj-Napoca, Romania., Zdrenghea M; Department of Hematology, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; Department of Hematology, Ion Chiricuta Oncology Institute, Cluj-Napoca, Romania., Buzoianu AD; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania., Tanase A; Department of Stem Cell Transplantation, Fundeni Clinical Institute, Bucharest, Romania; Department of Hematology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania., Einsele H; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; Medizinische Klinik Und Poliklinik II, Universitäts klinikum Würzburg, Würzburg, Germany., Kobold S; Division of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany; German Cancer Consortium (DKTK), Partner Site Munich, a partnership between the DKFZ Heidelberg and the LMU University Hospital, LMU Munich, Germany; German Center for Lung Research (DZL), partner site Munich, Germany; Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Zentrum München - German Research Center for Environmental Health Neuherberg, Germany., Tomuleasa C; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; Department of Anesthesia and Intensive Care, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; Intensive Care Unit, Emergency Clinical Hospital, Cluj-Napoca, Romania. Electronic address: ciprian.tomuleasa@umfcluj.ro. |
| Source: | Blood reviews [Blood Rev] 2026 Jan; Vol. 75, pp. 101354. Date of Electronic Publication: 2025 Nov 26. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 8708558 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1681 (Electronic) Linking ISSN: 0268960X NLM ISO Abbreviation: Blood Rev Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41318274 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: CARing about autoimmune disorders. Use of chimeric antigen receptor engineered T-cells in autoimmune diseases. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Tigu+AB%22">Tigu AB</searchLink>; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.<br /><searchLink fieldCode="AU" term="%22Nistor+M%22">Nistor M</searchLink>; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.<br /><searchLink fieldCode="AU" term="%22Gulei+D%22">Gulei D</searchLink>; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.<br /><searchLink fieldCode="AU" term="%22Constantinescu+CS%22">Constantinescu CS</searchLink>; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; Department of Anesthesia and Intensive Care, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; Intensive Care Unit, Emergency Clinical Hospital, Cluj-Napoca, Romania.<br /><searchLink fieldCode="AU" term="%22Kegyes+D%22">Kegyes D</searchLink>; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; Department of Hematology, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.<br /><searchLink fieldCode="AU" term="%22Cenariu+D%22">Cenariu D</searchLink>; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.<br /><searchLink fieldCode="AU" term="%22Muresan+X%22">Muresan X</searchLink>; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.<br /><searchLink fieldCode="AU" term="%22Munteanu+R%22">Munteanu R</searchLink>; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.<br /><searchLink fieldCode="AU" term="%22Feder+R%22">Feder R</searchLink>; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.<br /><searchLink fieldCode="AU" term="%22Jitaru+C%22">Jitaru C</searchLink>; Department of Hematology, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; Department of Hematology, Ion Chiricuta Oncology Institute, Cluj-Napoca, Romania.<br /><searchLink fieldCode="AU" term="%22Bancos+A%22">Bancos A</searchLink>; Department of Hematology, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; Department of Hematology, Ion Chiricuta Oncology Institute, Cluj-Napoca, Romania.<br /><searchLink fieldCode="AU" term="%22Santa+M%22">Santa M</searchLink>; Department of Hematology, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; Department of Hematology, Ion Chiricuta Oncology Institute, Cluj-Napoca, Romania.<br /><searchLink fieldCode="AU" term="%22Tomai+R%22">Tomai R</searchLink>; Department of Hematology, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; Department of Hematology, Ion Chiricuta Oncology Institute, Cluj-Napoca, Romania.<br /><searchLink fieldCode="AU" term="%22Damian+M%22">Damian M</searchLink>; Department of Hematology, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; Department of Hematology, Ion Chiricuta Oncology Institute, Cluj-Napoca, Romania.<br /><searchLink fieldCode="AU" term="%22Ivancuta+A%22">Ivancuta A</searchLink>; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.<br /><searchLink fieldCode="AU" term="%22Rus+I%22">Rus I</searchLink>; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.<br /><searchLink fieldCode="AU" term="%22Bojan+A%22">Bojan A</searchLink>; Department of Hematology, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; Department of Hematology, Ion Chiricuta Oncology Institute, Cluj-Napoca, Romania.<br /><searchLink fieldCode="AU" term="%22Zdrenghea+M%22">Zdrenghea M</searchLink>; Department of Hematology, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; Department of Hematology, Ion Chiricuta Oncology Institute, Cluj-Napoca, Romania.<br /><searchLink fieldCode="AU" term="%22Buzoianu+AD%22">Buzoianu AD</searchLink>; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.<br /><searchLink fieldCode="AU" term="%22Tanase+A%22">Tanase A</searchLink>; Department of Stem Cell Transplantation, Fundeni Clinical Institute, Bucharest, Romania; Department of Hematology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.<br /><searchLink fieldCode="AU" term="%22Einsele+H%22">Einsele H</searchLink>; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; Medizinische Klinik Und Poliklinik II, Universitäts klinikum Würzburg, Würzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Kobold+S%22">Kobold S</searchLink>; Division of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany; German Cancer Consortium (DKTK), Partner Site Munich, a partnership between the DKFZ Heidelberg and the LMU University Hospital, LMU Munich, Germany; German Center for Lung Research (DZL), partner site Munich, Germany; Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Zentrum München - German Research Center for Environmental Health Neuherberg, Germany.<br /><searchLink fieldCode="AU" term="%22Tomuleasa+C%22">Tomuleasa C</searchLink>; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; Department of Anesthesia and Intensive Care, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; Intensive Care Unit, Emergency Clinical Hospital, Cluj-Napoca, Romania. Electronic address: ciprian.tomuleasa@umfcluj.ro. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228708558%22">Blood reviews</searchLink> [Blood Rev] 2026 Jan; Vol. 75, pp. 101354. <i>Date of Electronic Publication: </i>2025 Nov 26. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8708558 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-1681 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220268960X%22">0268960X </searchLink><i>NLM ISO Abbreviation: </i>Blood Rev <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41318274 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.blre.2025.101354 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 101354 Titles: – TitleFull: CARing about autoimmune disorders. Use of chimeric antigen receptor engineered T-cells in autoimmune diseases. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Tigu AB – PersonEntity: Name: NameFull: Nistor M – PersonEntity: Name: NameFull: Gulei D – PersonEntity: Name: NameFull: Constantinescu CS – PersonEntity: Name: NameFull: Kegyes D – PersonEntity: Name: NameFull: Cenariu D – PersonEntity: Name: NameFull: Muresan X – PersonEntity: Name: NameFull: Munteanu R – PersonEntity: Name: NameFull: Feder R – PersonEntity: Name: NameFull: Jitaru C – PersonEntity: Name: NameFull: Bancos A – PersonEntity: Name: NameFull: Santa M – PersonEntity: Name: NameFull: Tomai R – PersonEntity: Name: NameFull: Damian M – PersonEntity: Name: NameFull: Ivancuta A – PersonEntity: Name: NameFull: Rus I – PersonEntity: Name: NameFull: Bojan A – PersonEntity: Name: NameFull: Zdrenghea M – PersonEntity: Name: NameFull: Buzoianu AD – PersonEntity: Name: NameFull: Tanase A – PersonEntity: Name: NameFull: Einsele H – PersonEntity: Name: NameFull: Kobold S – PersonEntity: Name: NameFull: Tomuleasa C IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2026 Jan Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1532-1681 Numbering: – Type: volume Value: 75 Titles: – TitleFull: Blood reviews Type: main |
| ResultId | 1 |